ISTH 2022 Congress

July 9-13, 2022. London, England, UK.

• Acquired Bleeding Disorders (75)
  • Coagulopathy of Major Bleeding (Trauma, PPH, Vascular/surgical, ECMO, GI bleeding, etc.) (31)
  • Management/Treatments of Acquired Bleeding (30)
  • Novel Therapies in the Management of Acquired Bleeding (14)
• Arterial Thromboembolism (75)
  • Acute Coronary Syndromes (9)
  • Atherosclerosis (10)
  • Atrial Fibrillation (18)
  • Cardiovascular Risk Factors (19)
  • Cerebrovascular Disorders (14)
  • Peripheral Artery Disease (5)
• Coagulation and Natural Anticoagulants (138)
  • Animal Models in Thrombosis and Hemostasis (10)
  • Coagulation Factors and Inhibitors (57)
  • Contact Pathway (16)
  • Critical Care and Perioperative (18)
  • FVIII/IX (2)
  • Hemostasis and Organ Dysfunction (7)
  • Microparticles (1)
  • Protein C Pathway (5)
  • Regulation of Coagulation (17)
  • Tissue Factor Pathway (5)
• COVID and Coagulation (172)
  • COVID and Coagulation, Basic Science (47)
  • COVID and Coagulation, Clinical (124)
• Diagnostics and OMICs (110)
  • Biomarkers of Thrombosis and Hemostasis (12)
  • Blood Components and Management (4)
  • Cellular Therapies (4)
  • Laboratory Diagnostics (77)
  • Nanotechnology and Novel Biomolecules (4)
• Fibrinolysis and Proteolysis (45)
  • Fibrinogen and Factor XIII (16)
  • Fibrinolytic Factors and Inhibitors (18)
  • Plasminogen Activation in the CNS and Immunity (2)
  • Thrombolytic Therapy (9)
• Hemophilia and Rare Bleeding Disorders (297)
  • Acquired Hemorrhagic Coagulation Disorders (10)
  • Disseminated Intravascular Coagulation (2)
  • Hemophilia - Basic (59)
  • Hemophilia - Clinical (133)
  • Hemophilia Gene Therapy (18)
  • Management of Bleeding and Trauma (23)
  • Novel Biotherapeutics in Hemophilia (20)
  • Rare Bleeding Disorders (32)
• Hemostatic Systems in Cancer, Inflammation and Immunity (76)
  • Coagulation Proteins Beyond Hemostasis (20)
  • Complement and Hemostatic System (5)
  • Infection and Hemostatic Factors (7)
  • Platelets and Cancer (18)
  • Platelets and Infection (6)
  • Platelets and Inflammation (16)
  • Proteases and Cancer (5)
• Nurses and Allied Health (4)
• Pediatrics (74)
  • Bleeding in Neonates and Children (25)
  • Thrombosis in Neonates and Children (49)
• Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies (216)
  • Acquired Thrombocytopenias (34)
  • ADAMTS13 and TTP (35)
  • Antiplatelet Therapy (9)
  • Blood Cells and Vessel Wall (36)
  • Endothelial Cell Signaling (12)
  • HIT (13)
  • HUS (4)
  • Inherited Thrombocytopenias (15)
  • Non-coding RNAs (3)
  • Non HUS/TTP Microangiopathies (2)
  • Platelet Antagonists and Novel Therapeutics (9)
  • Platelet Function Disorders, Acquired (7)
  • Platelet Function Disorders, Hereditary (20)
  • von Willebrand Factor Biology (21)
  • VWF and von Willebrand Factor Disorders - Clinical Conditions (43)
• Platelets and Megakaryocytes (164)
  • Megakaryocytes and Thrombopoiesis (31)
  • Platelet Function and Interactions (82)
  • Platelet Proteomics and Genomics (10)
  • Platelet Receptors (25)
  • Platelet Signaling (20)
• Vascular Biology (74)
  • Epigenetics, OMICs and Bioinformatics (8)
  • Inflammation and Sepsis (12)
  • Innate and Adaptive Immunity (5)
  • Protease Activated Receptors (3)
  • Stem Cells and Vascular Cell Growth (5)
• Venous Thromboembolism (299)
  • Antiphospholipid Syndrome (21)
  • Artificial Valves (2)
  • Cancer Associated Thrombosis (55)
  • Genetic Risk Factors of Thrombosis (15)
  • Post-thrombotic Syndrome (8)
  • Thrombophilia (23)
  • Visceral Vein Thrombosis (8)
  • VTE Diagnosis (27)
  • VTE Epidemiology (51)
  • VTE Prophylaxis (38)
  • VTE Treatment (51)
• Women’s Health (57)
  • Estrogens and Progestinics (8)
  • Pregnancy and Pregnancy Complications (48)